0th Law

Our Team

Wade Shen

Wade Shen

Evaluation Methods & Standards

Wade was the inaugural director of ARPA-H's Proactive Health Office, where he managed a portfolio of R&D programs that aim to dramatically increase the health span of Americans by increasing their capacity to avoid disease and the symptoms of disease for as long as possible.

Prior to ARPA-H, he served as Director of the National AI Initiative Office (NAIIO) at the White House in the Office of Science and Technology Policy (OSTP) and as program manager at the Defense Advanced Research Projects Agency (DARPA), where he ran a portfolio of AI/data science and hardware for AI programs. Wade was cofounder of Actuate, a nonprofit organization dedicated to bringing the ARPA model of innovation to societal applications outside of national security. He was also a researcher and manager at MIT's Lincoln Laboratory, where he worked on and oversaw research in AI and natural language understanding, and was co-founder and CTO of Vocentric Corporation, an embedded speech and speaker recognition startup.

Wade leads development of evaluation methods and engagement with the standards bodies.

Carolyn Shaw

Carolyn Shaw

Clinical Evaluation Program Development

Carolyn has over a decade of experience working at the intersection of research and development (R&D), innovation, and nonprofits. She currently works as a consultant at Strategic Engineering Solutions (SES), advising federal R&D clients. In her spare time, Carolyn loves running and reading fiction. Carolyn received her MBA from the Yale School of Management and BA from the University of Virginia.

Carolyn helps develop clinical-use and evaluation programs at 0th-law.ai.

Natasha Hunter

Natasha Hunter

Chief Medical Advisor

Natasha Hunter, MD, is an Associate Professor of Medicine at the University of Washington/Fred Hutchinson Cancer Center. She is a cancer researcher and practicing board-certified breast medical oncologist. She has served as an investigator on industry, cooperative-group and federally funded trials, with research interests cancer immunology and circulating tumor DNA as a marker of treatment response and survival in breast cancer.

Before joining UW, she trained in internal medicine at Beth Israel Deaconess Medical Center, and completed a fellowship in medical oncology at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center. Before earning her MD at Brown University, she worked as a journalist and earned an MA from Indiana University.

Tasha advises the company on health care strategy and real world deployment of new clinical care tools.